; Medtronic, Inc. (MDT) - Product Pipeline Analysis
Documents
Resources
Learning Center
Upload
Plans & pricing Sign in
Sign Out
Your Federal Quarterly Tax Payments are due April 15th Get Help Now >>

Medtronic, Inc. (MDT) - Product Pipeline Analysis

VIEWS: 205 PAGES: 262

Medtronic, Inc. (MDT) - Product Pipeline Analysis Summary This report is a source for data, analysis and actionable intelligence on the Medtronic, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date. Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. Scope - Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments. - Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase. - Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date. - Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application. - Data on relevant clinical trials and product patent details, wherever applicable. - Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility. Reasons to B

More Info
  • pg 1
									                                      Medtronic, Inc. (MDT) - Product Pipeline Analysis

     Reference Code: GDME738PD                                                                                                                   Publication Date: NOV 2010



     Company Snapshot                                                                 Company Overview
     Key Information
                                                                                       Medtronic, Inc. (Medtronic) is a medical technology company engaged in
      Medtronic, Inc., Key Facts                                                       the development, manufacture and marketing of a wide range of medical
                                                                                       devices, therapies and services used to treat chronic conditions such as
      Web Address                           www.medtronic.com
                                                                                       heart disease, spinal conditions, neurological disorders, vascular disease
      Turnover (in USD Million) 15,817                                                 and diabetes. It operates in seven business segments namely, Cardiac
                                                                                       Rhythm Disease Management (CRDM), Spinal Segment, Cardio Vascular
      Number of Employees                   39,273                                     segment, Neuromodulation segment, Diabetes segment,                Surgical
      Industry                              Pharmaceuticals and Healthcare-            Technologies segment and Physio-Control segment.
      Source:Primary / Secondary Research
      GlobalData



     Medtronic, Inc. Pipeline Products

     Medtronic, Inc. Key Pipeline Products by Equipment                                Medtronic, Inc. Key Pipeline Products by Therapy Area
     Type
     Equipment Type                            No of Products                         Therapy Area                                                           No of Products
     Peripheral Vascular Devices                   17                                 Diabetes mellitus                                                         11
     Interventional Cardiology                                    16                  Vertebral compression fractures                                            6
     Cardiac Rhythm Management                                    14                  Atherosclerosis                                                            5
     Spinal Surgery                                               13                  Cardiac arrhythmia                                                         5
     Neurostimulation Devices                                     9                   Coronary artery lesions                                                    4
     Electrophysiology                                            6                   Coronary bifurcation lesions                                               4
     Prosthetic Heart Valve                                       5                   Atrial fibrillation                                                        3
     Source: Primary / Secondary Research                                              Source: Primary / Secondary Research
     GlobalData                                                                        GlobalData


     Medtronic, Inc. Key Pipeline Products by Equipment Type




      Source: Primary / Secondary Research
      GlobalData
      Others indicates :- Neurostimulation Devices - 9%, Spinal Surgery - 12%, Cardiac Rhythm Management - 13%, Interventional Cardiology - 15%, Peripheral Vascular Devices -
      16%



     Medtronic, Inc. Key Pipeline Products by Development                              Medtronic, Inc. Key Pipeline Products by Trial Phase
     Stage
     Developmental Stage                       No of Products                         Trial Phase                                                            No of Products
     Clinicals                                 93                                     Phase IV                                                          11
     Pre-Clinicals                                            1                       Phase III                                                         10
     Early development                                        3                       Phase II                                                          14
     No Specific Phase                                       14                       Phase I                                                           12
     Source: Primary / Secondary Research                                              Source: Primary / Secondary Research
     GlobalData                                                                        GlobalData




Medtronic, Inc. (MDT) - Product Pipeline Analysis                                                                                                       Reference Code: GDME738PD

Source : www.globalcompanyintelligence.com                                                                                                                                       Page 1
     Table of Contents
     Table of Contents................................................................................................................................................................................................................................................................... 2
     List of Tables ........................................................................................................................................................................................................................................................................ 10
     List of Figures....................................................................................................................................................................................................................................................................... 20
     Medtronic, Inc. - Business Description................................................................................................................................................................................................................................. 21
     Key Facts ............................................................................................................................................................................................................................................................................. 22
     Medtronic, Inc. - Major Products and Services .................................................................................................................................................................................................................... 23
           Medtronic, Inc. Pipeline Products by Equipment Type .................................................................................................................................................................................................. 26
           Medtronic, Inc. Pipeline Products by Development Stage............................................................................................................................................................................................. 30
           Medtronic, Inc. Pipeline Products by Therapy Area ...................................................................................................................................................................................................... 33
           Medtronic, Inc. Pipeline Products by Trial Phase .......................................................................................................................................................................................................... 36
           Medtronic, Inc. Pipeline Products by Milestone Summary ............................................................................................................................................................................................ 39
           3Dx Thoracolumbar fixation system .............................................................................................................................................................................................................................. 43
                 Product Status......................................................................................................................................................................................................................................................... 43
                 Product Description ................................................................................................................................................................................................................................................. 43
           A-Mav disc ..................................................................................................................................................................................................................................................................... 43
                 Product Status......................................................................................................................................................................................................................................................... 43
                 Product Description ................................................................................................................................................................................................................................................. 43
                 A-Mav disc Clinical Trial .......................................................................................................................................................................................................................................... 43
           Ablation Frontiers Cardiac Ablation System .................................................................................................................................................................................................................. 45
                 Product Status......................................................................................................................................................................................................................................................... 45
                 Product Description ................................................................................................................................................................................................................................................. 45
                 Product Milestone ................................................................................................................................................................................................................................................... 45
                 Ablation Frontiers Cardiac Ablation System Clinical Trial ....................................................................................................................................................................................... 46
                 Product Patent Details ............................................................................................................................................................................................................................................ 49
           Activa PC-Refractory Epilepsy....................................................................................................................................................................................................................................... 52
                 Product Status......................................................................................................................................................................................................................................................... 52
                 Product Description ................................................................................................................................................................................................................................................. 52
           Advantage Supra ........................................................................................................................................................................................................................................................... 52
                 Product Status......................................................................................................................................................................................................................................................... 52
                 Product Description ................................................................................................................................................................................................................................................. 52
                 Product Milestone ................................................................................................................................................................................................................................................... 53
                 Advantage Supra Clinical Trial................................................................................................................................................................................................................................ 53
                 Product Patent Details ............................................................................................................................................................................................................................................ 54
           Advisa DR MRI SureScan Pacing System .................................................................................................................................................................................................................... 56
                 Product Status......................................................................................................................................................................................................................................................... 56
                 Product Description ................................................................................................................................................................................................................................................. 56
                 Product Milestone ................................................................................................................................................................................................................................................... 56
           Amplify rhBMP-2............................................................................................................................................................................................................................................................ 57
                 Product Status......................................................................................................................................................................................................................................................... 57
                 Product Description ................................................................................................................................................................................................................................................. 57
                 Product Milestone ................................................................................................................................................................................................................................................... 57
                 Amplify rhBMP-2 Clinical Trial................................................................................................................................................................................................................................. 58
           Aperius PercLID............................................................................................................................................................................................................................................................. 58
                 Product Status......................................................................................................................................................................................................................................................... 58
                 Product Description ................................................................................................................................................................................................................................................. 59
                 Product Milestone ................................................................................................................................................................................................................................................... 59
                 Aperius PercLID Clinical Trial ................................................................................................................................................................................................................................. 59
           Arctic Front CryoAblation Catheter System ................................................................................................................................................................................................................... 62
                 Product Status......................................................................................................................................................................................................................................................... 62
                 Product Description ................................................................................................................................................................................................................................................. 63
                 Product Milestone ................................................................................................................................................................................................................................................... 63
                 Arctic Front CryoAblation Catheter System Clinical Trial........................................................................................................................................................................................ 63
                 Product Patent Details ............................................................................................................................................................................................................................................ 69
           Artificial Pancreas - Closed loop system ....................................................................................................................................................................................................................... 71
                 Product Status......................................................................................................................................................................................................................................................... 71
                 Product Description ................................................................................................................................................................................................................................................. 71
                 Product Milestone ................................................................................................................................................................................................................................................... 71
                 Product Patent Details ............................................................................................................................................................................................................................................ 72
           Assurant Cobalt Iliac Stent ............................................................................................................................................................................................................................................ 72
                 Product Status......................................................................................................................................................................................................................................................... 72

Medtronic, Inc. (MDT) - Product Pipeline Analysis                                                                                                                                                                                                       Reference Code: GDME738PD

Source : www.globalcompanyintelligence.com                                                                                                                                                                                                                                                    Page 2
               Product Description ................................................................................................................................................................................................................................................. 72
               Product Milestone ................................................................................................................................................................................................................................................... 73
               Assurant Cobalt Iliac Stent Clinical Trial ................................................................................................................................................................................................................. 73
         Avion Bifurcation RX2.................................................................................................................................................................................................................................................... 74
               Product Status......................................................................................................................................................................................................................................................... 74
               Product Description ................................................................................................................................................................................................................................................. 74
               Product Patent Details ............................................................................................................................................................................................................................................ 74
         Avion Plus...................................................................................................................................................................................................................................................................... 75
               Product Status......................................................................................................................................................................................................................................................... 75
               Product Description ................................................................................................................................................................................................................................................. 75
               Product Patent Details ............................................................................................................................................................................................................................................ 76
         Bifurcated DES .............................................................................................................................................................................................................................................................. 76
               Product Status......................................................................................................................................................................................................................................................... 76
               Product Description ................................................................................................................................................................................................................................................. 77
         Bifurcation stent ............................................................................................................................................................................................................................................................. 77
               Product Status......................................................................................................................................................................................................................................................... 77
               Product Description ................................................................................................................................................................................................................................................. 77
               Product Milestone ................................................................................................................................................................................................................................................... 77
               Bifurcation stent Clinical Trial.................................................................................................................................................................................................................................. 78
               Product Patent Details ............................................................................................................................................................................................................................................ 79
         Bryan Revised Toolset................................................................................................................................................................................................................................................... 81
               Product Status......................................................................................................................................................................................................................................................... 81
               Product Description ................................................................................................................................................................................................................................................. 81
         Captivia Delivery System With Valiant Thoracic Stent Graft ......................................................................................................................................................................................... 82
               Product Status......................................................................................................................................................................................................................................................... 82
               Product Description ................................................................................................................................................................................................................................................. 82
               Product Milestone ................................................................................................................................................................................................................................................... 82
               Captivia Delivery System With Valiant Thoracic Stent Graft Clinical Trial .............................................................................................................................................................. 82
         Cardioblate Closure Left Atrial Appendage Occlusion Device ...................................................................................................................................................................................... 83
               Product Status......................................................................................................................................................................................................................................................... 83
               Product Description ................................................................................................................................................................................................................................................. 83
               Cardioblate Closure Left Atrial Appendage Occlusion Device Clinical Trial ........................................................................................................................................................... 83
               Product Patent Details ............................................................................................................................................................................................................................................ 84
         CareLink iPro Lightning ................................................................................................................................................................................................................................................. 85
               Product Status......................................................................................................................................................................................................................................................... 85
               Product Description ................................................................................................................................................................................................................................................. 85
         Chromis Deep................................................................................................................................................................................................................................................................ 85
               Product Status......................................................................................................................................................................................................................................................... 85
               Product Description ................................................................................................................................................................................................................................................. 85
               Chromis Deep Clinical Trial..................................................................................................................................................................................................................................... 86
               Product Patent Details ............................................................................................................................................................................................................................................ 86
         Chronicle ICD ................................................................................................................................................................................................................................................................ 87
               Product Status......................................................................................................................................................................................................................................................... 87
               Product Description ................................................................................................................................................................................................................................................. 87
               Product Milestone ................................................................................................................................................................................................................................................... 87
               Chronicle ICD Clinical Trial ..................................................................................................................................................................................................................................... 88
               Product Patent Details ............................................................................................................................................................................................................................................ 89
         Chronicle IHM ................................................................................................................................................................................................................................................................ 90
               Product Status......................................................................................................................................................................................................................................................... 90
               Product Description ................................................................................................................................................................................................................................................. 90
               Product Milestone ................................................................................................................................................................................................................................................... 90
               Chronicle IHM Clinical Trial..................................................................................................................................................................................................................................... 91
               Product Patent Details ............................................................................................................................................................................................................................................ 94
         Closed-Loop Brain Implant ............................................................................................................................................................................................................................................ 95
               Product Status......................................................................................................................................................................................................................................................... 95
               Product Description ................................................................................................................................................................................................................................................. 96
               Product Milestone ................................................................................................................................................................................................................................................... 96
         Comfort Sensor.............................................................................................................................................................................................................................................................. 96
               Product Status......................................................................................................................................................................................................................................................... 96
               Product Description ................................................................................................................................................................................................................................................. 96
         Complete SE SFA.......................................................................................................................................................................................................................................................... 97
               Product Status......................................................................................................................................................................................................................................................... 97
               Product Description ................................................................................................................................................................................................................................................. 97


Medtronic, Inc. (MDT) - Product Pipeline Analysis                                                                                                                                                                                                    Reference Code: GDME738PD

Source : www.globalcompanyintelligence.com                                                                                                                                                                                                                                                 Page 3
               Product Milestone ................................................................................................................................................................................................................................................... 97
               Complete SE SFA Clinical Trial .............................................................................................................................................................................................................................. 97
         Consulta CRT-P............................................................................................................................................................................................................................................................. 99
               Product Status......................................................................................................................................................................................................................................................... 99
               Product Description ................................................................................................................................................................................................................................................. 99
         CoreValve Delivery Catheter System With AccuTrak Stability Layer ............................................................................................................................................................................ 99
               Product Status......................................................................................................................................................................................................................................................... 99
               Product Description ................................................................................................................................................................................................................................................. 99
               Product Milestone ................................................................................................................................................................................................................................................... 99
         CoreValve ReValving System...................................................................................................................................................................................................................................... 100
               Product Status....................................................................................................................................................................................................................................................... 100
               Product Description ............................................................................................................................................................................................................................................... 100
               Product Milestone ................................................................................................................................................................................................................................................. 100
               CoreValve ReValving System Clinical Trial .......................................................................................................................................................................................................... 101
         Cristallo Ideale ............................................................................................................................................................................................................................................................. 109
               Product Status....................................................................................................................................................................................................................................................... 109
               Product Description ............................................................................................................................................................................................................................................... 109
               Cristallo Ideale Clinical Trial .................................................................................................................................................................................................................................. 109
               Product Patent Details .......................................................................................................................................................................................................................................... 110
         Diver C.E. MAX............................................................................................................................................................................................................................................................ 111
               Product Status....................................................................................................................................................................................................................................................... 111
               Product Description ............................................................................................................................................................................................................................................... 111
               Product Milestone ................................................................................................................................................................................................................................................. 111
         Endeavor Resolute ...................................................................................................................................................................................................................................................... 111
               Product Status....................................................................................................................................................................................................................................................... 111
               Product Description ............................................................................................................................................................................................................................................... 111
               Endeavor Resolute Clinical Trial ........................................................................................................................................................................................................................... 112
               Product Patent Details .......................................................................................................................................................................................................................................... 124
         Endurant Stent Graft System....................................................................................................................................................................................................................................... 124
               Product Status....................................................................................................................................................................................................................................................... 124
               Product Description ............................................................................................................................................................................................................................................... 124
               Product Milestone ................................................................................................................................................................................................................................................. 124
               Endurant Stent Graft System Clinical Trial............................................................................................................................................................................................................ 125
               Product Patent Details .......................................................................................................................................................................................................................................... 127
         Enlite Sensor ............................................................................................................................................................................................................................................................... 127
               Product Status....................................................................................................................................................................................................................................................... 127
               Product Description ............................................................................................................................................................................................................................................... 128
         Ensura MRI SureScan Pacing System ........................................................................................................................................................................................................................ 128
               Product Status....................................................................................................................................................................................................................................................... 128
               Product Description ............................................................................................................................................................................................................................................... 128
               Product Milestone ................................................................................................................................................................................................................................................. 128
         Falcon Bravo................................................................................................................................................................................................................................................................ 129
               Product Status....................................................................................................................................................................................................................................................... 129
               Product Description ............................................................................................................................................................................................................................................... 129
         Falcon CTO ................................................................................................................................................................................................................................................................. 129
               Product Status....................................................................................................................................................................................................................................................... 129
               Product Description ............................................................................................................................................................................................................................................... 129
         Falcon Forte................................................................................................................................................................................................................................................................. 130
               Product Status....................................................................................................................................................................................................................................................... 130
               Product Description ............................................................................................................................................................................................................................................... 130
         G5 Posterior Screw System......................................................................................................................................................................................................................................... 130
               Product Status....................................................................................................................................................................................................................................................... 130
               Product Description ............................................................................................................................................................................................................................................... 130
         GENius Multi-channel RF Generator ........................................................................................................................................................................................................................... 131
               Product Status....................................................................................................................................................................................................................................................... 131
               Product Description ............................................................................................................................................................................................................................................... 131
               Product Milestone ................................................................................................................................................................................................................................................. 131
               GENius Multi-channel RF Generator Clinical Trial................................................................................................................................................................................................ 131
               Product Patent Details .......................................................................................................................................................................................................................................... 133
         Hippocampus Renal RX Stent System ........................................................................................................................................................................................................................ 134
               Product Status....................................................................................................................................................................................................................................................... 134
               Product Description ............................................................................................................................................................................................................................................... 134
               Product Patent Details .......................................................................................................................................................................................................................................... 134


Medtronic, Inc. (MDT) - Product Pipeline Analysis                                                                                                                                                                                                   Reference Code: GDME738PD

Source : www.globalcompanyintelligence.com                                                                                                                                                                                                                                                Page 4
         IN.PACT Admiral Drug Eluting Balloon........................................................................................................................................................................................................................ 135
               Product Status....................................................................................................................................................................................................................................................... 135
               Product Description ............................................................................................................................................................................................................................................... 135
               Product Milestone ................................................................................................................................................................................................................................................. 135
               IN.PACT Admiral Drug Eluting Balloon Clinical Trial ............................................................................................................................................................................................ 135
         IN.PACT Amphirion Paclitaxel Eluting Balloon Catheter ............................................................................................................................................................................................. 137
               Product Status....................................................................................................................................................................................................................................................... 137
               Product Description ............................................................................................................................................................................................................................................... 137
               Product Milestone ................................................................................................................................................................................................................................................. 137
               IN.PACT Amphirion Paclitaxel Eluting Balloon Catheter Clinical Trial .................................................................................................................................................................. 138
         IN.PACT Falcon PTCA Balloon Catheter .................................................................................................................................................................................................................... 139
               Product Status....................................................................................................................................................................................................................................................... 139
               Product Description ............................................................................................................................................................................................................................................... 140
               Product Milestone ................................................................................................................................................................................................................................................. 140
         `IN.PACT Pacific Balloon Catheter .............................................................................................................................................................................................................................. 141
               Product Status....................................................................................................................................................................................................................................................... 141
               Product Description ............................................................................................................................................................................................................................................... 141
               Product Milestone ................................................................................................................................................................................................................................................. 141
         Infuse Bone Graft – Posterolateral Fusions................................................................................................................................................................................................................. 141
               Product Status....................................................................................................................................................................................................................................................... 141
               Product Description ............................................................................................................................................................................................................................................... 141
         Infuse Bone Graft-Cervical Fusion............................................................................................................................................................................................................................... 142
               Product Status....................................................................................................................................................................................................................................................... 142
               Product Description ............................................................................................................................................................................................................................................... 142
               Product Milestone ................................................................................................................................................................................................................................................. 142
         Integrity Coronary Stent System.................................................................................................................................................................................................................................. 143
               Product Status....................................................................................................................................................................................................................................................... 143
               Product Description ............................................................................................................................................................................................................................................... 143
               Product Milestone ................................................................................................................................................................................................................................................. 143
         Integrity DES................................................................................................................................................................................................................................................................ 143
               Product Status....................................................................................................................................................................................................................................................... 143
               Product Description ............................................................................................................................................................................................................................................... 144
         Intercept Epilepsy Control System............................................................................................................................................................................................................................... 144
               Product Status....................................................................................................................................................................................................................................................... 144
               Product Description ............................................................................................................................................................................................................................................... 144
               Product Milestone ................................................................................................................................................................................................................................................. 144
               Intercept Epilepsy Control System Clinical Trial ................................................................................................................................................................................................... 144
               Product Patent Details .......................................................................................................................................................................................................................................... 145
         Interstim Bowel Stimulator ........................................................................................................................................................................................................................................... 147
               Product Status....................................................................................................................................................................................................................................................... 147
               Product Description ............................................................................................................................................................................................................................................... 147
               Product Milestone ................................................................................................................................................................................................................................................. 147
               Interstim Bowel Stimulator Clinical Trial ................................................................................................................................................................................................................ 147
               Product Patent Details .......................................................................................................................................................................................................................................... 150
         InterStim II - 3058 ........................................................................................................................................................................................................................................................ 151
               Product Status....................................................................................................................................................................................................................................................... 151
               Product Description ............................................................................................................................................................................................................................................... 151
               Product Milestone ................................................................................................................................................................................................................................................. 152
               InterStim II - 3058 Clinical Trial ............................................................................................................................................................................................................................. 152
         iPro2 Professional CGM System ................................................................................................................................................................................................................................. 153
               Product Status....................................................................................................................................................................................................................................................... 153
               Product Description ............................................................................................................................................................................................................................................... 153
               Product Milestone ................................................................................................................................................................................................................................................. 153
         KyphX Bone Biopsy Device ......................................................................................................................................................................................................................................... 154
               Product Status....................................................................................................................................................................................................................................................... 154
               Product Description ............................................................................................................................................................................................................................................... 154
               Product Patent Details .......................................................................................................................................................................................................................................... 155
         KyphX Bone Filler Device ............................................................................................................................................................................................................................................ 155
               Product Status....................................................................................................................................................................................................................................................... 155
               Product Description ............................................................................................................................................................................................................................................... 155
               Product Patent Details .......................................................................................................................................................................................................................................... 155
         KyphX Elevate Inflatable Bone Tamp .......................................................................................................................................................................................................................... 156
               Product Status....................................................................................................................................................................................................................................................... 156


Medtronic, Inc. (MDT) - Product Pipeline Analysis                                                                                                                                                                                                  Reference Code: GDME738PD

Source : www.globalcompanyintelligence.com                                                                                                                                                                                                                                               Page 5
               Product Description ............................................................................................................................................................................................................................................... 156
               Product Patent Details .......................................................................................................................................................................................................................................... 156
         KyphX Exact Inflatable Bone Tamp ............................................................................................................................................................................................................................. 158
               Product Status....................................................................................................................................................................................................................................................... 158
               Product Description ............................................................................................................................................................................................................................................... 158
               Product Patent Details .......................................................................................................................................................................................................................................... 159
         KyphX Express Bone Biopsy Device ........................................................................................................................................................................................................................... 160
               Product Status....................................................................................................................................................................................................................................................... 160
               Product Description ............................................................................................................................................................................................................................................... 161
         KyphX Express Bone Filler Device .............................................................................................................................................................................................................................. 161
               Product Status....................................................................................................................................................................................................................................................... 161
               Product Description ............................................................................................................................................................................................................................................... 161
               Product Patent Details .......................................................................................................................................................................................................................................... 161
         KyphX Express Inflatable Bone Tamp ......................................................................................................................................................................................................................... 162
               Product Status....................................................................................................................................................................................................................................................... 162
               Product Description ............................................................................................................................................................................................................................................... 162
               Product Patent Details .......................................................................................................................................................................................................................................... 162
         KyphX Express Osteo Introducer System ................................................................................................................................................................................................................... 163
               Product Status....................................................................................................................................................................................................................................................... 163
               Product Description ............................................................................................................................................................................................................................................... 163
         KyphX High-Viscosity Radiopaque Bone Cement ....................................................................................................................................................................................................... 163
               Product Status....................................................................................................................................................................................................................................................... 163
               Product Description ............................................................................................................................................................................................................................................... 163
         KyphX Latitude Curette................................................................................................................................................................................................................................................ 164
               Product Status....................................................................................................................................................................................................................................................... 164
               Product Description ............................................................................................................................................................................................................................................... 164
               KyphX Latitude Curette Clinical Trial .................................................................................................................................................................................................................... 164
               Product Patent Details .......................................................................................................................................................................................................................................... 167
         KyphX One-Step Osteo Introducer System ................................................................................................................................................................................................................. 167
               Product Status....................................................................................................................................................................................................................................................... 167
               Product Description ............................................................................................................................................................................................................................................... 167
         KyphX Osteo Introducer System ................................................................................................................................................................................................................................. 168
               Product Status....................................................................................................................................................................................................................................................... 168
               Product Description ............................................................................................................................................................................................................................................... 168
               Product Patent Details .......................................................................................................................................................................................................................................... 168
         KyphX Xpander Inflatable Bone Tamp ........................................................................................................................................................................................................................ 169
               Product Status....................................................................................................................................................................................................................................................... 169
               Product Description ............................................................................................................................................................................................................................................... 169
               KyphX Xpander Inflatable Bone Tamp Clinical Trial ............................................................................................................................................................................................. 169
               Product Patent Details .......................................................................................................................................................................................................................................... 171
         KyphX Xpander Inflation Syringe................................................................................................................................................................................................................................. 176
               Product Status....................................................................................................................................................................................................................................................... 176
               Product Description ............................................................................................................................................................................................................................................... 176
               Product Patent Details .......................................................................................................................................................................................................................................... 176
         LeadLess Pacemaker .................................................................................................................................................................................................................................................. 181
               Product Status....................................................................................................................................................................................................................................................... 181
               Product Description ............................................................................................................................................................................................................................................... 181
         Maris ............................................................................................................................................................................................................................................................................ 181
               Product Status....................................................................................................................................................................................................................................................... 181
               Product Description ............................................................................................................................................................................................................................................... 182
               Maris Clinical Trial ................................................................................................................................................................................................................................................. 182
               Product Patent Details .......................................................................................................................................................................................................................................... 183
         Maverick Artificial Lumbar Disc.................................................................................................................................................................................................................................... 183
               Product Status....................................................................................................................................................................................................................................................... 183
               Product Description ............................................................................................................................................................................................................................................... 184
               Product Milestone ................................................................................................................................................................................................................................................. 184
               Maverick Artificial Lumbar Disc Clinical Trial ........................................................................................................................................................................................................ 184
               Product Patent Details .......................................................................................................................................................................................................................................... 186
         MiniMed Paradigm x54 System LGS........................................................................................................................................................................................................................... 187
               Product Status....................................................................................................................................................................................................................................................... 187
               Product Description ............................................................................................................................................................................................................................................... 188
         Multi-Array Septal Catheter ......................................................................................................................................................................................................................................... 188
               Product Status....................................................................................................................................................................................................................................................... 188


Medtronic, Inc. (MDT) - Product Pipeline Analysis                                                                                                                                                                                                      Reference Code: GDME738PD

Source : www.globalcompanyintelligence.com                                                                                                                                                                                                                                                    Page 6
               Product Description ............................................................................................................................................................................................................................................... 188
               Multi-Array Septal Catheter Clinical Trial .............................................................................................................................................................................................................. 188
               Product Patent Details .......................................................................................................................................................................................................................................... 189
         Neural Implant-Parkinson's Disease............................................................................................................................................................................................................................ 190
               Product Status....................................................................................................................................................................................................................................................... 190
               Product Description ............................................................................................................................................................................................................................................... 190
         Nex Sensor .................................................................................................................................................................................................................................................................. 190
               Product Status....................................................................................................................................................................................................................................................... 190
               Product Description ............................................................................................................................................................................................................................................... 191
         Next Generation Insulin Pump..................................................................................................................................................................................................................................... 191
               Product Status....................................................................................................................................................................................................................................................... 191
               Product Description ............................................................................................................................................................................................................................................... 191
         O-Arm 3.2 .................................................................................................................................................................................................................................................................... 191
               Product Status....................................................................................................................................................................................................................................................... 191
               Product Description ............................................................................................................................................................................................................................................... 191
         O-Mav .......................................................................................................................................................................................................................................................................... 192
               Product Status....................................................................................................................................................................................................................................................... 192
               Product Description ............................................................................................................................................................................................................................................... 192
               O-Mav Clinical Trial ............................................................................................................................................................................................................................................... 192
         Occipital Nerve Stimulation system ............................................................................................................................................................................................................................. 192
               Product Status....................................................................................................................................................................................................................................................... 192
               Product Description ............................................................................................................................................................................................................................................... 193
               Product Milestone ................................................................................................................................................................................................................................................. 193
               Occipital Nerve Stimulation system Clinical Trial .................................................................................................................................................................................................. 194
         Pacific Xtreme.............................................................................................................................................................................................................................................................. 195
               Product Status....................................................................................................................................................................................................................................................... 195
               Product Description ............................................................................................................................................................................................................................................... 195
               Product Milestone ................................................................................................................................................................................................................................................. 195
         Pacing Lead (Model 4296 LV Lead) ............................................................................................................................................................................................................................ 196
               Product Status....................................................................................................................................................................................................................................................... 196
               Product Description ............................................................................................................................................................................................................................................... 196
               Product Milestone ................................................................................................................................................................................................................................................. 196
               Pacing Lead (Model 4296 LV Lead) Clinical Trial ................................................................................................................................................................................................. 196
         Paradigm Veo System ................................................................................................................................................................................................................................................. 197
               Product Status....................................................................................................................................................................................................................................................... 197
               Product Description ............................................................................................................................................................................................................................................... 197
               Product Milestone ................................................................................................................................................................................................................................................. 198
               Product Patent Details .......................................................................................................................................................................................................................................... 198
         Patch Pump ................................................................................................................................................................................................................................................................. 198
               Product Status....................................................................................................................................................................................................................................................... 198
               Product Description ............................................................................................................................................................................................................................................... 198
         Pre-filled Insulin Reservoirs ......................................................................................................................................................................................................................................... 199
               Product Status....................................................................................................................................................................................................................................................... 199
               Product Description ............................................................................................................................................................................................................................................... 199
               Product Patent Details .......................................................................................................................................................................................................................................... 199
         Prestige LP .................................................................................................................................................................................................................................................................. 199
               Product Status....................................................................................................................................................................................................................................................... 199
               Product Description ............................................................................................................................................................................................................................................... 200
               Product Milestone ................................................................................................................................................................................................................................................. 200
               Prestige LP Clinical Trial ....................................................................................................................................................................................................................................... 200
               Product Patent Details .......................................................................................................................................................................................................................................... 203
         PrimeADVANCED-Heart Failure ................................................................................................................................................................................................................................. 205
               Product Status....................................................................................................................................................................................................................................................... 205
               Product Description ............................................................................................................................................................................................................................................... 205
               Product Milestone ................................................................................................................................................................................................................................................. 205
               PrimeADVANCED-Heart Failure Clinical Trial ...................................................................................................................................................................................................... 205
         Protecta CRT-D ........................................................................................................................................................................................................................................................... 206
               Product Status....................................................................................................................................................................................................................................................... 206
               Product Description ............................................................................................................................................................................................................................................... 206
         Protecta DR ................................................................................................................................................................................................................................................................. 207
               Product Status....................................................................................................................................................................................................................................................... 207
               Product Description ............................................................................................................................................................................................................................................... 207
         Protecta Total Shock Reduction ICD ........................................................................................................................................................................................................................... 207


Medtronic, Inc. (MDT) - Product Pipeline Analysis                                                                                                                                                                                                     Reference Code: GDME738PD

Source : www.globalcompanyintelligence.com                                                                                                                                                                                                                                                  Page 7
               Product Status....................................................................................................................................................................................................................................................... 207
               Product Description ............................................................................................................................................................................................................................................... 207
               Protecta Total Shock Reduction ICD Clinical Trial................................................................................................................................................................................................ 208
         Protecta VR ................................................................................................................................................................................................................................................................. 209
               Product Status....................................................................................................................................................................................................................................................... 209
               Product Description ............................................................................................................................................................................................................................................... 209
         Protecta XT CRT-D...................................................................................................................................................................................................................................................... 209
               Product Status....................................................................................................................................................................................................................................................... 209
               Product Description ............................................................................................................................................................................................................................................... 209
         Protecta XT DR............................................................................................................................................................................................................................................................ 210
               Product Status....................................................................................................................................................................................................................................................... 210
               Product Description ............................................................................................................................................................................................................................................... 210
         Protecta XT VR............................................................................................................................................................................................................................................................ 211
               Product Status....................................................................................................................................................................................................................................................... 211
               Product Description ............................................................................................................................................................................................................................................... 211
         Pulmonary Vein Ablation Catheter............................................................................................................................................................................................................................... 211
               Product Status....................................................................................................................................................................................................................................................... 211
               Product Description ............................................................................................................................................................................................................................................... 211
               Product Milestone ................................................................................................................................................................................................................................................. 212
               Pulmonary Vein Ablation Catheter Clinical Trial ................................................................................................................................................................................................... 212
               Product Patent Details .......................................................................................................................................................................................................................................... 214
         Resolute Integrity......................................................................................................................................................................................................................................................... 214
               Product Status....................................................................................................................................................................................................................................................... 214
               Product Description ............................................................................................................................................................................................................................................... 215
               Product Milestone ................................................................................................................................................................................................................................................. 215
               Resolute Integrity Clinical Trial.............................................................................................................................................................................................................................. 215
         Restore Sensor............................................................................................................................................................................................................................................................ 216
               Product Status....................................................................................................................................................................................................................................................... 216
               Product Description ............................................................................................................................................................................................................................................... 216
         Revo MRI Pacemaker System..................................................................................................................................................................................................................................... 216
               Product Status....................................................................................................................................................................................................................................................... 216
               Product Description ............................................................................................................................................................................................................................................... 216
               Product Milestone ................................................................................................................................................................................................................................................. 217
               Revo MRI Pacemaker System Clinical Trial ......................................................................................................................................................................................................... 217
               Product Patent Details .......................................................................................................................................................................................................................................... 218
         Scuba Co-Cr Peripheral Stent System ........................................................................................................................................................................................................................ 220
               Product Status....................................................................................................................................................................................................................................................... 220
               Product Description ............................................................................................................................................................................................................................................... 220
               Scuba Co-Cr Peripheral Stent System Clinical Trial ............................................................................................................................................................................................. 220
         Skipper Deep ............................................................................................................................................................................................................................................................... 222
               Product Status....................................................................................................................................................................................................................................................... 222
               Product Description ............................................................................................................................................................................................................................................... 222
               Product Patent Details .......................................................................................................................................................................................................................................... 222
         Skylor........................................................................................................................................................................................................................................................................... 223
               Product Status....................................................................................................................................................................................................................................................... 223
               Product Description ............................................................................................................................................................................................................................................... 223
               Skylor Clinical Trial................................................................................................................................................................................................................................................ 223
         Soletra - Refractory Epilepsy ....................................................................................................................................................................................................................................... 225
               Product Status....................................................................................................................................................................................................................................................... 225
               Product Description ............................................................................................................................................................................................................................................... 225
               Product Milestone ................................................................................................................................................................................................................................................. 225
               Soletra - Refractory Epilepsy Clinical Trial............................................................................................................................................................................................................ 225
               Product Patent Details .......................................................................................................................................................................................................................................... 231
         SubMarine Rapido ....................................................................................................................................................................................................................................................... 232
               Product Status....................................................................................................................................................................................................................................................... 232
               Product Description ............................................................................................................................................................................................................................................... 232
               Product Patent Details .......................................................................................................................................................................................................................................... 232
         T-VAC Tip-Versatile Ablation Catheter ........................................................................................................................................................................................................................ 233
               Product Status....................................................................................................................................................................................................................................................... 233
               Product Description ............................................................................................................................................................................................................................................... 233
               Product Milestone ................................................................................................................................................................................................................................................. 233
               T-VAC Tip-Versatile Ablation Catheter Clinical Trial............................................................................................................................................................................................. 233
               Product Patent Details .......................................................................................................................................................................................................................................... 234


Medtronic, Inc. (MDT) - Product Pipeline Analysis                                                                                                                                                                                                     Reference Code: GDME738PD

Source : www.globalcompanyintelligence.com                                                                                                                                                                                                    
								
To top